alloxan has been researched along with telmisartan in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Albayrak, F; Bilen, H; Cetinkaya, R; Halici, Z; Keles, ON; Suleyman, H; Unal, B; Uyanik, A | 1 |
| Fukuoka, N; Inoue, T; Kikumoto, Y; Kitagawa, M; Maeshima, Y; Makino, H; Masuoka, N; Morinaga, H; Ogino, K; Saeki, M; Sugiyama, H; Takiue, K; Wang, DH | 1 |
2 other study(ies) available for alloxan and telmisartan
| Article | Year |
|---|---|
Does telmisartan prevent hepatic fibrosis in rats with alloxan-induced diabetes?
Topics: Alloxan; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Diabetes Mellitus, Experimental; Fibrosis; Immunohistochemistry; Liver; Male; Microscopy, Electron; Rats; Rats, Wistar; Telmisartan; Transforming Growth Factor beta | 2009 |
Sensitization to alloxan-induced diabetes and pancreatic cell apoptosis in acatalasemic mice.
Topics: Acatalasia; Alloxan; Angiotensin II Type 1 Receptor Blockers; Animals; Apoptosis; Benzimidazoles; Benzoates; Blood Glucose; Body Weight; Catalase; Cell Death; Diabetes Mellitus, Experimental; Glutathione Peroxidase; Homozygote; Hyperglycemia; Insulin-Secreting Cells; Male; Mice; Mice, Inbred C3H; Mice, Knockout; Mice, Mutant Strains; Superoxide Dismutase; Telmisartan | 2010 |